Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Osaka looks to become global life sciences hub
Positive data moving breast cancer trial forward
Engineering dendritic cells boosts cancer immunotherapy
Ambros Therapeutics launches with $125m to take on complex regional pain syndrome type 1
ADEL and Sanofi sign $1.04bn licence agreement for Alzheimer’s therapy
Aukera Therapeutics emerges from stealth
FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial
Platform to test new cancer treatments